Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Takeda Pharmaceutical Ltd ADR (TAK)

Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,287,120
  • Shares Outstanding, K 3,181,875
  • Annual Sales, $ 29,420 M
  • Annual Income, $ 994,060 K
  • EBIT $ 4,591 M
  • EBITDA $ 11,000 M
  • 60-Month Beta 0.54
  • Price/Sales 1.54
  • Price/Cash Flow 4.20
  • Price/Book 0.93

Options Overview Details

View History
  • Implied Volatility 37.88% ( +7.85%)
  • Historical Volatility 17.53%
  • IV Percentile 71%
  • IV Rank 36.93%
  • IV High 80.58% on 07/10/24
  • IV Low 12.88% on 09/05/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 40
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 1,419
  • Open Int (30-Day) 1,399

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.51
  • Growth Rate Est. (year over year) +195,782.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.21 +0.30%
on 11/20/24
14.24 -6.95%
on 11/05/24
-0.90 (-6.36%)
since 10/21/24
3-Month
13.21 +0.30%
on 11/20/24
15.08 -12.14%
on 08/23/24
-1.69 (-11.31%)
since 08/21/24
52-Week
12.57 +5.37%
on 06/20/24
15.08 -12.14%
on 08/23/24
-0.77 (-5.49%)
since 11/21/23

Most Recent Stories

More News
Here is the Year-End FOMC Outlook

It took a while to get here, but the Fed finally cut interest rates last week. U.S. and European share markets reacted positively to the FOMC policy directive for a 50 bps Fed Funds rate cut. That was...

NPSNY : 45.4999 (-0.26%)
PKG : 244.12 (+0.01%)
TAK : 13.30 (+0.08%)
The Zacks Analyst Blog Highlights Takeda Pharma, Naspers and Packaging Corp. of America

For Immediate ReleaseChicago, IL – September 24, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...

NPSNY : 45.4999 (-0.26%)
PKG : 244.12 (+0.01%)
TAK : 13.30 (+0.08%)
Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut

Wave Life Sciences has received recent Wall Street price targets forecasting big upside. The company has a potentially "industry-leading" treatment.

WVE : 14.86 (+4.21%)
GSK : 33.38 (+0.09%)
TAK : 13.30 (+0.08%)
New Study Reveals How Classical Music Could Revolutionize Depression Care

In a groundbreaking study, Chinese scientists have revealed that classical music could be a powerful tool in the fight against treatment-resistant depression, a condition that affects nearly 50% of patients...

ALZN : 1.3000 (-0.76%)
NBIX : 125.73 (+1.98%)
TAK : 13.30 (+0.08%)
AXSM : 95.85 (+1.32%)
BIIB : 157.07 (+0.69%)
3 'Strong Buy'-Rated Stocks to Buy Now on the Dip

These outstanding growth stocks are worth buying on the dip.

AMZN : 198.49 (-2.16%)
$SPX : 5,936.86 (+0.33%)
GEHC : 82.32 (-3.04%)
GD : 281.41 (+0.49%)
OVID : 1.0500 (+0.96%)
TAK : 13.30 (+0.08%)
One Ultra-Cheap High-Yield Dividend Stock to Buy

Now may be a good time for dividend investors to consider loading up on this stock.

TAK : 13.30 (+0.08%)
Orphan Drugs Worth $64 Billion by 2028 and This Micro Cap Could Have One by That Time

There are very good reasons that stocks generally gain in value after a company receives %OrphanDrug designation (ODD). A study published in Orphanet Journal of Rare Diseases showed that the average stock...

SNY : 47.86 (+0.17%)
TAK : 13.30 (+0.08%)
NRX.VN : 0.710 (-6.58%)
BMY : 58.24 (+0.62%)
NRX : 0.14 (+7.69%)
Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and Older

If Approved, Lanadelumab Will be the First Long-Term Prophylactic Treatment of HAE Available in the EU for Patients Under the Age of Six. Positive Opinion...

TAK : 13.30 (+0.08%)
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris

One of these high-yield pharma stocks stands out as a better buy right now.

PFE : 25.03 (+0.36%)
TAK : 13.30 (+0.08%)
VTRS : 13.23 (+0.76%)
2 Ultra-Cheap High-Yield Dividend Stocks to Buy Now

These two high-yield dividend stocks are attractive buys right now.

TAK : 13.30 (+0.08%)
T : 23.00 (+0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide...

See More

Key Turning Points

3rd Resistance Point 13.71
2nd Resistance Point 13.60
1st Resistance Point 13.44
Last Price 13.30
1st Support Level 13.17
2nd Support Level 13.06
3rd Support Level 12.90

See More

52-Week High 15.08
Fibonacci 61.8% 14.12
Fibonacci 50% 13.83
Fibonacci 38.2% 13.53
Last Price 13.30
52-Week Low 12.57

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar